dQ&A data show that users' perceptions of an algorithm's aggressiveness strongly impact satisfaction and NPS.
Results from dQ&A Patient Voice Q1 2025 Update
Our survey of 190 U.S. endocrinologists finds GLP-1 and SGLT2 prescribing at 90%+ and rising, while many patients resist starting basal insulin.
